Search Results - Damla Gunenc

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Antifibrotic Effect of Lactulose on a Methotrexate-Induced Liver Injury Model by Banu Taskin, Mümin Alper Erdoğan, Gürkan Yiğittürk, Damla Günenç, Oytun Erbaş

    Published in Gastroenterology Research and Practice (2017-01-01)
    Get full text
    Article


  2. 2

    A Narrative Review of RAS Mutations in Early-Stage Colorectal Cancer: Mechanisms and Clinical Implications by Hasan Cagri Yildirim, Damla Gunenc, Elvina Almuradova, Osman Sutcuoglu, Suayib Yalcin

    Published in Medicina (2025-02-01)
    Get full text
    Article


  3. 3

    RAS Mutations in Advanced Colorectal Cancer: Mechanisms, Clinical Implications, and Novel Therapeutic Approaches by Osman Sütcüoğlu, Hasan Çağrı Yıldırım, Elvina Almuradova, Damla Günenç, Şuayib Yalçın

    Published in Medicina (2025-06-01)
    Get full text
    Article


  4. 4

    Successful application of chemosaturation with percutaneous hepatic perfusion in metastatic uveal melanoma patient progressing after systemic treatment options: a case report by Damla Gunenc, Ahmet Anil Ozluk, Utku Mahir Yıldırım, Paolo A. Ascierto, Burcak Karaca

    Published in Frontiers in Oncology (2024-04-01)
    Get full text
    Article


  5. 5

    Predicting immune-related adverse events in patients with melanoma: the role of interleukin-7 rs16906115 polymorphism and lymphocyte dynamics by Fatma Pınar Açar, Caner Acar, Damla Gunenc, Çağlar Arisoy, Asli Ece Solmaz, Asli Gecgel, Haydar Çağatay Yüksel, Gökhan Şahin, Oguzcan Ozkan, Zeynep Sila Gokdere, Nilay Duman, Burçak Karaca

    Published in Frontiers in Immunology (2025-06-01)
    Get full text
    Article


  6. 6

    Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designs by Tian Zhang, Patrick M Forde, Elad Sharon, Scot Ebbinghaus, Michael B Atkins, Mark Stewart, Ryan J Sullivan, Elizabeth Barksdale, Wendy Selig, Gina Fusaro, Damla Gunenc, Dena Battle, Robyn Burns, Marc S Hurlbert

    Published in Journal for ImmunoTherapy of Cancer (2023-05-01)
    Get full text
    Article


  7. 7

    Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: A multicenter study by Hasan Çağrı Yıldırım, Emel Mutlu, Elvin Chalabiyev, Miraç Özen, Merve Keskinkılıç, Sercan Ön, Abdussamet Çelebi, Bengü Dursun, Ömer Acar, Seda Kahraman, Musa Barış Aykan, Ömür Kaman, Akif Doğan, Atike Pınar Erdoğan, Özde Melisa Celayir, Damla Günenç, Deniz Can Güven, İbrahim Vedat Bayoğlu, Tuğba Yavuzşen, İlhan Hacıbekiroğlu, Mevlüde İnanç, Saadettin Kılıçkap, Şuayib Yalçın, Sercan Aksoy

    Published in Breast (2022-12-01)
    Get full text
    Article


  8. 8

    Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncolo... by Nargiz Majidova, Sendag Yaslıkaya, Maral Martin Mıldanoglu, Alper Coskun, Duygu Ercan Uzundal, Taha Koray Sahin, Arif Akyildiz, Sinem Akbas, Ufuk Camanlı, Elif Sahin, Huseyin Atacan, Ismail Bayrakcı, Teoman Sakalar, Ceren Mordag Cicek, Damla Gunenc, Nurullah İlhan, Olcun Umit Unal, Ozkan Alan, Buket Hamitoglu, Esra Ozen Engin, Nadiye Sever, Ali Kaan Guren, Ahmet Unsal, Murat Araz, Bulent Erdogan, Musa Barıs Aykan, Fatih Selcukbiricik, Deniz Can Guven, Nuriye Ozdemir, Ahmet Bilgehan Sahin, Ahmet Bilici, Ismail Oguz Kara, Suayip Yalcın, Osman Kostek

    Published in The Turkish Journal of Gastroenterology (2025-05-01)
    Get full text
    Article


Search Tools: